Telaprevir Patent Expiration

1. Incivek patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7820671 VERTEX PHARMS Peptidomimetic protease inhibitors
Feb, 2025

(7 months from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8529882 VERTEX PHARMS Peptidomimetic protease inhibitors
Aug, 2021

(2 years ago)

US8431615 VERTEX PHARMS Dose forms
May, 2028

(3 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) May 23, 2016

NCE-1 date: 24 May, 2015

Market Authorisation Date: 23 May, 2011

Treatment: Method of treating chronic hepatitis c

Dosage: TABLET

More Information on Dosage

INCIVEK family patents

Family Patents